378 related articles for article (PubMed ID: 20460108)
1. Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells.
Saad FA; Torres M; Wang H; Graham L
Biochem Biophys Res Commun; 2010 Jun; 396(4):944-9. PubMed ID: 20460108
[TBL] [Abstract][Full Text] [Related]
2. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
3. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
[TBL] [Abstract][Full Text] [Related]
4. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
[TBL] [Abstract][Full Text] [Related]
5. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells.
Reynaud C; Gleyzal C; Jourdan-Le Saux C; Sommer P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1237-47. PubMed ID: 10643973
[TBL] [Abstract][Full Text] [Related]
6. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase silencing impairs keratinocyte differentiation in a reconstructed-epidermis model.
Le Provost GS; Debret R; Cenizo V; Aimond G; Pez F; Kaniewski B; André V; Sommer P
Exp Dermatol; 2010 Dec; 19(12):1080-7. PubMed ID: 20812961
[TBL] [Abstract][Full Text] [Related]
8. Chromatin supraorganization, mitotic abnormalities and proliferation in cells with increased or down-regulated lox expression: Indirect evidence of a LOX-histone H1 interaction in vivo.
Mello ML; Alvarenga EM; Vidal Bde C; Di Donato A
Micron; 2011 Jan; 42(1):8-16. PubMed ID: 20888776
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
10. Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential.
Li W; Nugent MA; Zhao Y; Chau AN; Li SJ; Chou IN; Liu G; Kagan HM
J Cell Biochem; 2003 Jan; 88(1):152-64. PubMed ID: 12461785
[TBL] [Abstract][Full Text] [Related]
11. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
12. The complete derived amino acid sequence of human lysyl oxidase and assignment of the gene to chromosome 5 (extensive sequence homology with the murine ras recision gene).
Mariani TJ; Trackman PC; Kagan HM; Eddy RL; Shows TB; Boyd CD; Deak SB
Matrix; 1992 Jun; 12(3):242-8. PubMed ID: 1357535
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
[TBL] [Abstract][Full Text] [Related]
14. Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.
Gao L; Wu C; Fu F; You X; Ma X; Qin F; Li T; Wang R; Yuan J
J Cell Mol Med; 2018 Mar; 22(3):2018-2022. PubMed ID: 29278308
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
16. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.
Mercier N; Kakou A; Challande P; Lacolley P; Osborne-Pellegrin M
Toxicol Appl Pharmacol; 2009 Sep; 239(3):258-67. PubMed ID: 19524603
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells.
Thaler R; Spitzer S; Rumpler M; Fratzl-Zelman N; Klaushofer K; Paschalis EP; Varga F
Bone; 2010 Mar; 46(3):703-9. PubMed ID: 19895920
[TBL] [Abstract][Full Text] [Related]
19. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase regulates MMTV promoter: indirect evidence of histone H1 involvement.
Oleggini R; Di Donato A
Biochem Cell Biol; 2011 Dec; 89(6):522-32. PubMed ID: 21999391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
